Long-Term Side Effects of Ozempic: What Clinical Researchers and Sponsors Should Know
Sep 30th, 2025 in
Glossary
Ozempic (semaglutide) is a GLP-1 receptor agonist initially approved for managing type 2 diabetes and now also prescribed—under various brands—for chronic weight management. Its benefits are clinically meaningful: improved glycemic control, cardiovascular risk reduction, and[...]